Effcacy of Dexmedetomidine mixed with Ropivacaine for brachial plexus nerve block combined with intravenous anesthesia in patients undergoing shoulder arthroscopic surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800018414

Enrollment

Unknown

Registered

2018-09-17

Start date

2018-09-16

Completion date

Unknown

Last updated

2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Injuries and Disorders

Interventions

R:Brachial plexus nerve block with ropivacaine

R+D:Ropivacaine mixed with dexmedetomidine for brachial plexus block

C:Intravenous anesthesia

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. patients who signed a consent form;; 2. Patients undergoing selective unilateral shoulder arthroscopic surgery; 3. 18-65 years old; 4. ASA classification I-II; 5. BMI 18-24 kg/m2

Exclusion criteria

Exclusion criteria: 1. Coagulation disorder or receiving anticoagulation therapy; 2. Infection of puncture site; 3. Diabetic peripheral neuropathy; 4. Long-term opioid analgesics or alcoholism; 5. Mental and cognitive disorders; 6. Patients with anxiety or depression; 7. Pregnant or lying-in women; 8. Other situations that are considered inappropriate for this study by other researchers.

Design outcomes

Primary

Measure	Time frame
The amount of anaesthesia in operation;Time for spontaneous breathing recovery;awakening time;extubation time;VAS score at rest;VAS score for active functional exercise;VAS score for continuous passive movement;Biceps muscle strength;Analgesic dosage within 24 h after operation;	—

Countries

China

Contacts

Public ContactLiu Xuesheng

The First Affiliated Hospital of Anhui Medical University?

liu711029@hotmail.com+86 62922344

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026